Skip Navigation

W. Harry Feinstone Department of Molecular Microbiology and Immunology

MMI In the News 

December 1, 2020
Popular Science

Vaccines could be out by the end of 2020, but reaching everyone will take time
The past few weeks have been nothing but good news for COVID-19 vaccines. On Friday, Pfizer applied for emergency use authorization from the Food and Drug Administration (FDA) after announcing that its vaccine is 95 percent effective. Moderna isn’t far behind.
William Moss is quoted.

December 1, 2020
WPFW

Monday Morning QB [Radio]
William Moss
discusses vaccine development and distribution as Moderna and Pfizer vaccines draw closer to becoming available.

Global Health NOW

Global Health NOW is an essential daily read for the global health community. Get it delivered to your inbox daily.

Subscribe

 

November 30, 2020
WebMD

AstraZeneca Plans More Testing of COVID-19 Vaccine
Pharmaceutical company Astra Zeneca will conduct more clinical trials to clear up questions about the effectiveness of its coronavirus vaccine
Andy Pekosz is quoted.

November 30, 2020
WHYY - NPR

Why contact tracing isn’t the COVID solution we thought it would be
Because it is such a resource- and labor-intensive containment tool, contact tracing in Philadelphia and the rest of Pennsylvania never ramped up to the levels recommended to effectively contain the coronavirus. The stretches when the city’s contact tracing resources could keep pace with the virus came only during the periods when there was minimal community spread.
Emily Gurley is quoted

November 30, 2020
BBC

Vaccines in Africa [Video]
Bill Moss discusses vaccine availability in Africa, estimating the vaccines won't be available to much of the continent until late 2021. 

November 30, 2020
Bloomberg

AstraZeneca Vaccine Trial Likely Needs a Restart: Johns Hopkins [Video]
Andy Pekosz discusses confusion over the AstraZeneca Covid-19 vaccine trial and the rising number of hospitalizations in Europe.

November 25, 2020
Star Tribune

EXPLAINER: China's claims of coronavirus on frozen foods
China says it has detected the coronavirus on packages of imported frozen food, but how valid are its claims and how serious is the threat to public health?
Andy Pekosz is quoted.

November 25, 2020
WMAR

Third COVID-19 vaccine shows promising results [Video]
It's been 10 months since the identification of COVID-19 and already, there are three vaccines with late-stage trials showing they are highly effective. Oxford-AstraZeneca is the latest, along with Pfizer and Moderna.
Bill Moss is featured.

November 25, 2020
Sinclair Broadcast Group [via WBFF]

Vaccines are on the way, but distribution could face challenges
Some nations have already rejected the idea of mandatory vaccinations. Much like lockdown mandates and stay-at-home orders that have been issued in the United States from the beginning of the COVID-19 pandemic, compulsory vaccination orders cannot be made by the federal government.
Joanne Rosen and Bill Moss are quoted.

November 25, 2020
The Associated Press

Keep the mask: A vaccine won’t end the US crisis right away
Don’t even think of putting the mask away anytime soon. Despite the expected arrival of COVID-19 vaccines in just a few weeks, it could take several months — probably well into 2021 — before things get back to something close to normal in the U.S. and Americans can once again go to the movies, cheer at an NBA game or give Grandma a hug.
Bill Moss is quoted.

November 24, 2020
1010WCSI.com

How does Oxford-AstraZeneca’s coronavirus vaccine work?
Following news of up to 90% coronavirus vaccine efficacy, AstraZeneca and Oxford University’s effort involves a more traditional method, as opposed to other vaccine candidate platforms. The Oxford-AstraZeneca vaccine involves an inactivated common cold virus isolated from chimpanzees, altered with genes to express the spike protein of the SARS-CoV-2 virus.
Bill Moss is quoted.

November 24, 2020
Sinclair Broadcast Group [via WBFF]

COVID-19 Vaccine development could shape the future of immunization
The method of vaccine development, first introduced as a concept in 1961, has been dubbed “revolutionary” by epidemiologists and has only been in serious development since the early 2010s when Moderna was formed. The COVID-19 pandemic pushed mRNA vaccine development into overdrive this year, fueled by government and private funding from across the globe.
Bill Moss is quoted.

November 24, 2020
Fortune

COVID vaccines won’t come fast enough to save struggling businesses. But plasma might [Opinion]
Positive results from these outpatient plasma trials could radically affect how quickly society and the economy return to normal—even as we wait for promising vaccines and drugs to be proven both “safe” and “effective,” the FDA’s standard for approval for broader use.
David Sullivan wrote the article.

November 24, 2020
FoxNews.com

How does Oxford-AstraZeneca’s coronavirus vaccine work?
Following news of up to 90% coronavirus vaccine efficacy, AstraZeneca and Oxford University’s effort involves a more traditional method, as opposed to other vaccine candidate platforms.
Bill Moss is quoted

Noveber 23, 2020
WBAL

Questions surround timeline of potential coronavirus vaccine distribution [Video]
Among the first of the questions that lie ahead for a potential coronavirus vaccine are who will get the vaccine and when? If all goes well, the first doses of a coronavirus vaccine could be available by the end of the year, according to a John Hopkins University expert. But that's where the questions start.
Bill Moss is featured.

November 23, 2020
Bloomberg

What Emergency FDA Authorization Means for Covid-19 Vaccine [Video]
Andy Pekosz offers insight into emergency authorization of a vaccine as Pfizer Inc. and BioNTech SE plan to file Friday for use of their coronavirus vaccine in December.

November 19, 2020
WUSA

VERIFY: What is a Messenger RNA vaccine? [Video]
Both Pfizer and Moderna say they are close to a vaccine for COVID-19. In both cases, they are a type of brand new vaccine.
Bill Moss is featured.

November 19, 2020
TIME

The U.S. COVID-19 Outbreak Is Worse Than It’s Ever Been. Why Aren’t We Acting Like It?
Nothing about the current COVID-19 explosion should come as a surprise. As the virus spread throughout summer and fall, experts repeatedly warned winter would be worse. So it has. The U.S. is now locked in a deadly cycle of setting, then shattering, records for new cases and hospitalizations.
Bill Moss is quoted.

November 18, 2020
Newsweek

Why Moderna's COVID Vaccine Has a 'Huge Advantage' Over Pfizer's
Moderna's COVID vaccine is easier to store, transport, and prepare than Pfizer's, experts have told Newsweek, giving it a "huge advantage" if and when the time comes for them to be rolled out across the U.S.
Bill Moss is quoted.

November 17, 2020
Bloomberg

Dr. Sabra Klein on the Gender Risk Factor of Covid-19 [Video]
Sabra Klein, Professor of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, explains why gender is an important risk factor for Covid-19 and weighs on our progress toward a vaccine.

November 16, 2020
SELF

Measles Infections Are Skyrocketing Because of Low Vaccination Rates
Measles infections worldwide have risen dramatically from their historic low in 2016, ringing alarm bells for public health experts around the globe. In 2019, the global death rate for measles was more than 50% higher than in 2016, and total cases increased by a whopping 556%, according to a joint report released by the Centers for Disease Control and Prevention and the World Health Organization.
Bill Moss is quoted.

November 16, 2020
Science News

Measles has come back with a vengeance in the last several years
Measles has come back with a vengeance around the world in recent years, wiping out steep declines in cases seen since the start of the new century.
Bill Moss is quoted.

November 16, 2020
TIME

Why You May Not Be Able to Get Pfizer's Frontrunner COVID-19 Vaccine
Pfizer’s promising COVID-19 vaccine must be stored at about -70° C (-94° F)—a temperature cold enough to harden ice cream into a spoon-breaking block of ice, and that only specialized freezers can produce. Those cold storage requirements are raising serious questions about who could get the Pfizer vaccine if it’s approved, and when.
Bill Moss is quoted.

November 13, 2020
MarketWatch

Are rapid COVID-19 tests the way to get everyone traveling again? [Opinion]
Vaccines are a method of delayed antibody generation, and a vaccine for COVID-19 clearly would move us closer to resuming normal life. Except a vaccine represents just one approach to dealing with COVID-19 and, most likely, is not the panacea that we all long for.
David Sullivan wrote the piece.

November 13, 2020
Bloomberg

Covid-19 Vaccine Distribution Could Pose a Challenge: Johns Hopkins [Video]
Andy Pekosz discusses hopes pinned on a Covid-19 vaccine, the Covid outbreak in Denmark’s mink population, and the reliability of coronavirus testing.

November 13, 2020
Bloomberg

Latest on a Coronavirus Vaccine [Podcast]
William Moss, Executive Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health, provides a coronavirus and vaccine update.

November 13, 2020
NBCNews.com

'Breakthrough finding' reveals why certain Covid-19 patients die
Research shows Covid-19 patients with life-threatening illness have antibodies that disable key immune system proteins called interferons.
Sabra Klein is quoted.

November 12, 2020
The Baltimore Sun

Maryland hospitals rush to buy ultra-cold freezers to provide COVID-19 vaccines a warm welcome
The freezers, which can hold about 4,000 doses each and cost between $10,000 and $20,000, are part of a larger, complex logistical distribution effort for potential vaccines from Pfizer or Moderna, which have both been tested in Maryland. But they represent among the biggest potential physical hurdles for distribution.
Andy Pekosz is quoted.

November 11, 2020
Scripps [via KRTV]

COVID-19 vaccine: Experts say it could begin to be distributed by the end of 2020 [Video]
As of this week, we have optimistic news regarding phase-three efficacy results from biopharmaceutical company Pfizer – which has been collaborating with German company BioNTech.
Bill Moss is featured.

November 10, 2020
WMAR

COVID-19 vaccine closer to reality [Video]
On Monday night we were closer to a potential Coronavirus vaccine. Pfizer Incorporated and BioNTech announced they’ve created a vaccine that is 90% effective in preventing Coronavirus.
Bill Moss is featured.

November 6, 2020
Bloomberg

U.S. Registers Two Days of 100,000 Covid Cases: Johns Hopkins [Video]
Andy Pekosz discusses the surge in U.S. coronavirus cases, hospitalization and mortality in the current wave of illness, and provides an update on coronavirus vaccine trials.

November 6, 2020
The New York Times

Nasal Spray Prevents Covid Infection in Ferrets, Study Finds
Scientists at Columbia University have developed a treatment that blocks the virus in the nose and lungs, is inexpensive and needs no refrigeration.
Arturo Casadevall is quoted.

November 3, 2020
NBCNews.com

Covid-19 antibodies diminish over time, but experts say there's no reason to be alarmed
Most experts agree that drops in antibody levels over time are expected, and that these declines are not altogether concerning.
Arturo Casadevall is quoted.

October 30, 2020
Bloomberg

Gender Importance in COVID-19 Illness [Podcast]
Sabra Klein, Professor of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, discusses why gender is an important a risk factor for COVID-19.

October 30, 2020
Bloomberg

Need Targeted Interventions to Curb Virus Spread: Johns Hopkins [Video]
Andy Pekosz discusses the increased rate of Covid infections as the weather turns cooler, acting to prevent hospitalizations, and what type of data we can expect from coronavirus vaccine trials.

October 29, 2020
WBAL

Hopkins gets grant to create research center to study coronavirus immunity
The Johns Hopkins University School of Medicine and the Bloomberg School of Public Health will create a new research center to study COVID-19 immunity. Researchers announced Wednesday that they received a five-year grant from the National Cancer Institute, which is part of the National Institutes of Health.
Sabra Klein is quoted.

October 29, 2020
The Baltimore Sun

New Hopkins center aims to explain why some become severely sick from COVID-19, fuel better treatments
Johns Hopkins researchers have launched a center to better understand how people’s immune systems respond to the coronavirus, information that could explain why some become more severely sick from COVID-19, the illness caused by the virus.
Sabra Klein is quoted.

October 28, 2020
WebMD

Patients With Worst COVID May Be Key Plasma Donors
Factors such as sex, age and severity of the disease may help identify COVID-19 survivors who have high levels of antibodies that can protect against the disease, a new study suggests.
Sabra Klein, study-lead, is quoted. 

October 23, 2020
STAT

Blood plasma showed no benefit in Covid-19 patients in trial — a finding that could re-energize debate
The findings, published in BMJ, could re-energize the debate over whether blood plasma is an effective treatment for the disease.
Arturo Casadevall is quoted.

October 23, 2020
Bloomberg

Covid Vaccine Likely Not 100% Effective: Johns Hopkins’ Pekosz [Video]
Andy Pekosz discusses realistic expectations for a coronavirus vaccine.

October 22, 2020
Voice of America

Who's In Line for COVID-19 Vaccines?
There won't be enough vaccinations for everyone at first. Hard decisions have to be made about who gets it and who doesn't. So, public health experts are laying out guidelines that aim to do the most good with a limited resource.
Bill Moss is quoted.

October 21, 2020
Cleveland.com

Older men who survive coronavirus appear to be best source of plasma containing valuable antibodies
Older men who have recovered from COVID-19 coronavirus may be the best source of plasma containing antibodies that could help protect others from the disease, new research suggests.
Sabra Klein, study co-lead, is quoted.

October 21, 2020
CNBC.com

Severe COVID-19 patients may be best donors for plasma therapy: Study
COVID-19 patients who are sick enough to be hospitalised are likely to have high levels of antibodies that can protect against the disease and maybe the best donors for convalescent plasma therapy, according to a study.
Sabra Klein, study co-lead, is quoted.

October 21, 220
CNN.com

Blood from sickest Covid-19 patients may be the best for convalescent plasma treatment
Blood from the most severely ill Covid-19 patients may be the best for use in convalescent plasma therapy, according to a new study from Johns Hopkins University.
Sabra Klein, study co-lead, is quoted.

October 19, 2020
The Huffington Post

What We Know About Oestrogen's 'Protective Effect' Against Covid-19
Early on in the pandemic, it became obvious that men – as well as older women – were more susceptible to negative outcomes from Covid-19. Men, especially, are more likely to be hospitalized by the virus and end up in intensive care. They are also twice more likely to die from the virus as women. It led researchers to hypothesize that the female sex hormone oestrogen might have some kind of protective effect.
Sabra Klein is quoted.

October 19, 2020
Bloomberg

Wearing Masks Will Help Keep Economies Open: Johns Hopkins [Video]
Andy Pekosz says it's "quite clear" wearing masks reduces cases of Covid-19 infections and will help prevent an economic lockdown.

October 16, 2020
Gray TV DC

The military’s war on COVID-19 [Video]
The United States military fights terrorism, saves lives during natural disasters, and now, its latest mission is the war on coronavirus. This is the biggest role the military has ever played in preparing for vaccine distribution to the public. And it is also the most ambitious timeline for developing, manufacturing, and delivering a vaccine.
Bill Moss is featured.

October 15, 2020
Bloomberg

Vaccine Development Process Can Be Safely Accelerated: Johns Hopkins [Video]

William Moss discusses ways to safely accelerate the coronavirus vaccine development process, challenges in delivering a vaccine to patients, and the differences between antibody treatments and a vaccine.

October 14, 2020
ABCNews.com

Some states raising doubts about federal tests sent to nursing homes, citing shaky reliability
Several states have curtailed using coronavirus testing equipment in nursing homes that was provided by the Trump Administration after concerns were raised about the results, including false positives that risk mistakenly sending vulnerable seniors into special COVID isolation wings that could ultimately expose them to the virus.
Emily Gurley is quoted.

October 12, 2020
NHK World - Japan

Securing Equitable Distribution of COVID-19 Vaccines [Video]
Many countries are rushing to secure COVID-19 vaccines for their own population's use, and wealthy nations are funding research to procure massive amounts of doses. Some developing countries are trying to secure vaccines, which may not yet be proven safe, raising concerns that there will be discrepancies in vaccine distribution. Should the most vulnerable people and countries have early access to vaccines?
Bill Moss is featured.

October 12, 2020
NPR

Coronavirus FAQ: What's The Deal With The '15 Minute Rule'?
That "15-minute rule" is the Centers for Disease Control and Prevention's guideline for defining a close contact of an infected person. But experts say the risk of infection is a lot more nuanced than that guidance might imply.
Emily Gurley is quoted.

October 5, 2020
Maryland Public Television

State Circle: October 2, 2020 [Video]
Andy Pekosz is featured at the 1:50 mark.

October 5, 2020
People Magazine

President Donald Trump’s Preexisting Conditions Put Him at Higher Risk of Severe COVID-19
Emily Gurley is quoted.

October 5, 2020
Newsweek

Amy Coney Barrett Had COVID-19 This Summer—What Are Her Reinfection Risks?
Bill Moss is quoted.

October 2, 2020
Brown Daily Herald

COVID-19 blood-based treatment clinical trials come to Rhode Island
Researchers at Rhode Island Hospital and Johns Hopkins University study the efficacy of potential COVID-19 treatment for early stages of illness.
David Sullivan is quoted.

October 2, 2020
CGTN

The Heat: Fears of second wave of Covid-19 [Video]
Coronavirus deaths worldwide are near 1 million, most of them here in the United States: more than 2 hundred thousand lives lost. And the outlook is dire for the country: COVID-19 infections rose in 21 states last week. It could impact schools reopening and the easing of restrictions.
Bill Moss is featured.

October 2, 2020
WIRED

This Congressperson Wants to Rev Up Covid Testing
On Thursday, Mikie Sherrill, a freshman congressperson from New Jersey, plans to introduce the SPEEDY Act, which would tie federal reimbursement to test result speeds.
Emily Gurley is quoted.

October 2, 2020
Bloomberg

Study finds Trump was 'the largest driver of the COVID-19 misinformation' early in pandemic[Video]
Andy Pekosz discusses President Donald Trump testing positive for Covid-19 and the potential issues he faces as part of a high-risk group.

October 1, 2020
NHK

When Could a COVID-19 Vaccine Be Ready? [Video]
As the coronavirus pandemic still sweeps around the world with second waves already erupting in some countries, pharmaceutical companies and research institutes around the world are fast-tracking the development of COVID-19 vaccines. Some scientists say that vaccine trials and approvals take months or even years. However, US President Trump claims one will be available before the presidential election. So, when will we have a safe and effective vaccine?
Bill Moss is featured.

September 28, 2020
KUSI News

Johns Hopkins conducting two COVID-19 clinical trials at UC San Diego [Video]
Two COVID-19 clinical trials are currently being conducted locally at UC San Diego and there is an urgent need to find participants. 
David Sullivan is featured.

September 28, 2020
The Hub

For scientists, a 'healthy debate' about convalescent plasma
In 'The Wall Street Journal', Johns Hopkins immunologist Arturo Casadevall explains the different federal responses to the COVID-19 treatment and why it's normal to lack consensus in science
Arturo Casadevall is mentioned.

September 25, 2020
Nature

Convalescent plasma falls flat in first randomized trial
Plasma from individuals who have recovered from COVID-19 could benefit sick patients, but definitive evidence for or against convalescent plasma is still lacking.
Arturo Casadevall is quoted.

September 25, 2020
Bloomberg

Herd Immunity Not a Realistic Answer to Covid-19: Johns Hopkins [Video]
Andy Pekosz discusses the varying effects of coronavirus on different patients, studies on mutations in the virus, and what is to be expected of a successful vaccine.

September 24, 2020
UPI

Experts unsure about COVID-19, flu co-infection, but expect U.S. to find out
Becoming ill with both COVID-19 and the seasonal flu is possible, but it's unclear whether one virus makes the other one worse, experts said this week.
Andy Pekosz and Dan Salmon are quoted.

September 24, 2020
WebMD

Report: States Need to Track COVID-19 Data Better
While all 50 states and the District of Columbia have COVID-19 data dashboards, the data reported is inconsistent, incomplete, and inaccessible in most locations, a report from Resolve to Save Lives concludes.
Andy Pekosz and Dan Salmon are quoted

September 24, 2020
Route Fifty

Flu Season Could Further Strain Public Health Systems
The symptoms of the flu and coronavirus are similar and experts warn confusion over the two could overburden Covid-19 testing capacity.
Andy Pekosz and Dan Salmon are quoted.

September 24, 2020
Newsy

Doctors Warn About Challenges Ahead Of A 'Twindemic'
Symptoms for COVID-19 and the flu are almost identical, like body and muscle aches. One major difference, COVID-19 patients often lose smell or taste. The same people are at high risk for both.
Andy Pekosz and Dan Salmon are quoted.

September 24, 2020
Roll Call

Flu could strain health system already burdened by COVID-19
A rough flu season could compound the problems the COVID-19 pandemic has already caused in the United States, and public health experts are warning that a mild flu season in the Southern hemisphere may not mean Americans will experience the same thing.
Andy Pekosz and Dan Salmon are quoted.

September 24, 2020
The Hill 

Rising coronavirus cases spark fears of harsh winter
After surpassing another grim milestone — 200,000 confirmed coronavirus deaths — the U.S. is bracing for an increase in lives lost this fall and winter as the pandemic collides with flu season.
Andy Pekosz is quoted.

September 24, 2020
Bloomberg

Bloomberg DayBreak [Podcast]
Andy Pekosz discusses the U.S. response to the coronavirus pandemic as the country surpasses 200,000 deaths.
He is featured at the 15:40 mark.

September 23, 2020
Boston Herald 
Flu and coronavirus could make for twin pandemics, burdening testing capacity and hospitals
The impending flu season coupled with the ongoing coronavirus pandemic could make for an even greater public health challenge this winter, burdening testing capacity and hospitals, according to Johns Hopkins experts.
Andy Pekosz and Dan Salmon are quoted.

September 23, 2020
News 12 - Westchester

Same tactics, different threat – Flu season poses new risk amid pandemic  [Video]
As the weather gets colder, Americans are facing another viral threat: the flu.Doctors at the Johns Hopkins Bloomberg School of Public Health say social distancing and wearing masks will help people avoid the flu, as well as the coronavirus. Andy Pekosz is featured.

September 23, 2020
WBFF

Doctors Stress Importance of Flu Shots, Warn of Possible 'Twindemic' this Fall [Video]
Doctors are worried about a possible 'twindemic' this fall, warning of what could happen when flu season and COVID-19 overlap.
Andy Pekosz and Dan Salmon are featured.

September 23, 2020
WMAR

Doctors worried about fall 'Twindemic' [Video]
Just in time for the start of fall, health officials at Johns Hopkins University are warning the public to be aware of the so-called “twin-demic” of the flu and the coronavirus.
Andy Pekosz and Dan Salmon are featured.

September 23, 2020
WJZ

‘Twin-Demic’ | Health Officials Warn Coronavirus, Flu Season Could Stretch Healthcare System To Limits [Video]
COVID-19 has now killed more than 200,000 people in the US. Johns Hopkins doctors are worried about a double hit with the flu this fall.
Andy Pekosz and Dan Salmon are featured. 

September 23, 2020
WTOP

Johns Hopkins health experts emphasize importance of flu shots, warn of flu, coronavirus ‘twin-demic’
Health experts from Johns Hopkins University in Baltimore are warning of a flu and coronavirus “twin-demic,” and they are urging people to get their flu shots so as not to overwhelm an already stetched-out health care system. Andy Pekosz and Dan Salmonare quoted.

September 23, 2020
Business Insider 

Supply shortages are forcing restrictions on who can get a COVID-19 test, and it's happening at the worst possible time
A shortage of a chemical used to process the COVID-19 test has caused healthcare systems across the US to limit who is able to get a test — right before the start of the flu season — The Wall Street Journal reported.
Andy Pekosz and Amesh Adalja are quoted.

September 23, 2020
The Guardian 

Flu vaccine critical to avoid stretching US healthcare amid Covid, scientists warn
A national public health campaign promoting the flu vaccine is urgently needed to avoid stretched healthcare services being overwhelmed this winter as the US faces cold season while still struggling to gain control of the coronavirus pandemic, scientists have warned.
Dan Salmon and Andy Pekosz are quoted.

September 23, 2020
CBSNews.com

When will a coronavirus vaccine really be ready?
As much of America enters its seventh month of quarantine measures, more than 200,000 people have died from the coronavirus, and the mental and financial health of the country is wearing thin. Hopes of returning to normalcy are now pinned on one thing: finding a vaccine.
Bill Moss is quoted.

Septmember 23, 2020
The Wall Street Journal
A Little Debate on Plasma Is Healthy for Science [Opinion]

How can two federal agencies come to different conclusions on a topic of such great importance in the middle of an epidemic? Understanding the dispute requires a little history and also thinking about how experts evaluate evidence.
Arturo Casadevall coauthored the piece

September 21, 2020
Fox19 - Cincinnati

Volunteers needed for COVID-19 plasma trials at UC’s College of Medicine [Video]
A study of two new possible treatments for COVID-19 from Johns Hopkins University and University of Cinncinnati's College of Medicine will use convalescent blood plasma to test its effectiveness as outpatient therapy. The trial will help determine whether antibodies from people who have recovered from COVID-19 can help those who have been recently exposed or have been recently been diagnosed and have symptoms.
David Sullivan is featured.

September 21, 2020
WJAR - Rhode Island

Rhode Island Hospital is part of national trial involving convalescent plasma [Video]
Researchers worked to prevent the progression of COVID-19 early on. Rhode Island Hospital is one of 30 test sites nationally. This research centers around using a century-old technology: convalescent plasma. Right now, it’s being used as a treatment in the hospital setting for some of our sickest COVID-19 patients.
David Sullivan is featured.

September 21, 2020
WCVB5 - Worcester

Worcester researchers part of nationwide COVID-19 plasma study [Video]
A nationwide COVID-19 study that is looking at infection prevention and curative early treatment is now underway, and researchers in Worcester are looking for your help.
David Sullivan is featured.

September 21, 2020
The Baltimore Sun

Johns Hopkins seeks Baltimore-area participants for studies on using coronavirus antibodies to prevent, treat infection
Johns Hopkins University is seeking Baltimore- and Annapolis-area residents who recently have been diagnosed with or exposed to the coronavirus for two clinical trials studying the effectiveness of blood plasma with virus antibodies in preventing and treating infections of COVID-19.
David Sullivan is mentioned.

September 18, 2020
KJZZ

The Coronavirus Vaccine Race — And Its Hidden Hurdles[Radio]
Around the globe, labs and factories are racing to test and produce more than a billion doses of coronavirus vaccine.To shrink a 10-year marathon into a 10-month sprint, they are merging institutional knowledge with novel bioscience methods.
Bill Moss is interviewed.

September 18, 2020
Bloomberg

Avoiding a Large Covid-19 Second Wave Is Possible: Johns Hopkins[Video]
Andy Pekosz discusses the ebb and flow of covid-19 in the United States as the nation nears 200,000 virus deaths and steps to try to avoid a second wave of infections.

September 17, 2020
Sharecare

Can You Get COVID-19 More Than Once?
Are COVID-19 survivors really at risk of getting it again? The answer to that question isn’t clear—at least not yet. There is no definitive proof that recovering from COVID-19 and producing antibodies to SARS-CoV-2 means people won’t get the disease a second time. David Sullivan is quoted.

September 17, 2020
WMAR

COVID-19 antibody treatment trial looking for volunteers [Video]
With the uncertainty of what fall will bring, researchers are working hard to find a solution for COVID-19.
David Sullivan is featured.

September 16, 2020
The Scientist

Indian Study Shows No Survival Benefit of Plasma in COVID-19
The US Food and Drug Administration (FDA) recently granted emergency use authorization (EUA) for its use, although the absence of randomized controlled trials (RCTs) has led to skepticism about its effectiveness among experts.
Arturo Casadevall is quoted. 

September 15, 2020
NPR

General Public Won't Receive COVID-19 Vaccine Until Mid To Late 2021, Doctor Predicts [Radio]
When a safe and effective COVID-19 vaccine becomes available, it's a complex process to distribute it and make it accessible to everyone who needs it.
William Moss is interviewed.

September 14, 2020
Bloomberg

Covid-19 Is Not a Benign Disease in Children: Johns Hopkins [Video]
Andy Pekosz discusses the pause of AstraZeneca’s phase three vaccine trial, new information on children and Covid-19, and how colleges and universities are handling coronavirus outbreaks.

September 10, 2020
C-SPAN

Dr. William Moss on COVID-19 Vaccine Development [Video]
William Moss, executive director of the Johns Hopkins Bloomberg School of Public Health International Vaccines Center, talks about the national and international effort to develop a COVID-19 vaccine.

September 9, 2020
Forbes

8 High Achievers Share How They Are Managing Pandemic Related Challenges
For high achievers, it’s not a question of if they will get through the latest hiccup, as they have confidence that they will. The question for them is how and when.
Peter Agre is quoted.

September 8, 2020
The Washington Post

A common North American mouse can catch and spread the coronavirus in labs, studies show
Deer mice, the most abundant mammal native to North America, can catch the coronavirus and pass it to other mice in laboratory settings, raising a remote possibility that they could become a reservoir for the pathogen in nature and transmit it to humans.
Sabra Klein is quoted.

September 8, 2020
The Baltimore Sun

Maryland will allow Big Tech to track if someone with the coronavirus comes near you. Should you let them?
Gov. Larry Hogan announced this week that the state would adopt the tech giants’ jointly developed software, Exposure Notification Express, or ENX, which uses smartphones to alert users if they have had contact over the past 14 days with someone who has tested positive for the virus.
Emily Gurley is quoted.

September 8, 2020
Radiolab

Fungus Amungus [Radio]
Six years ago, a new infection began popping up in four different hospitals on three different continents, all around the same time. It wasn’t a bacteria, or a virus. It was ... a killer fungus. No one knew where it came from, or why. Arturo Casadevall is featured.

August 28, 2020
The Washington Post

Controversial change in guidelines about coronavirus testing directed by the White House coronavirus task force
A shift this week in government testing guidelines for Americans exposed to the novel coronavirus was directed by the White House’s coronavirus task force, alarming outside public health experts who warn the change could hasten the disease’s spread.
David Sullivan and Jennifer Nuzzo are quoted.

August 27, 2020
The New York Times

Why Does the Coronavirus Hit Men Harder? A New Clue
The coronavirus may infect anyone, young or old, but older men are up to twice as likely to become severely sick and to die as women of the same age. Why? The first study to look at immune response by sex has turned up a clue:
Sabra Klein is quoted

August 26, 2020
USA Today

COVID-19 tracking apps, supported by Apple and Google, begin showing up in app stores
Four months after Apple and Google announced an unusual collaboration to help public-health authorities track the novel coronavirus, apps built on their privacy-optimized Exposure Notification framework have begun arriving in the U.S.
Emily Gurley is quoted.

August 26, 2020
The Huffington Post

Why Trump’s Desperate Bid For A Win On COVID-19 Puts Lives At Risk
For the last few weeks, the FDA has been wrestling with whether to authorize plasma therapy on a nonexperimental basis, which would mean doctors could prescribe it on the spot.
Arturo Casadevall is quoted.

August 25, 2020
Healio

FDA OKs convalescent plasma for COVID-19 amid questions about its usefulness
The FDA authorized the emergency use of convalescent plasma as a therapy for patients hospitalized with COVID-19, saying the “known and potential benefits” of the technique outweigh any risks. However, others questioned the timing of the emergency use authorization (EUA) while trials assessing convalescent plasma for COVID-19 therapy are ongoing.
Arturo Casadevall is quoted.

August 25, 2020
Science Magazine

In FDA’s green light for treating COVID-19 with plasma, critics see thin evidence—and politics
The authorization for convalescent plasma could allow more hospitalized patients to receive the antibody-rich plasma, which is donated by people who have recovered from the disease. But in the wake of Trump’s announcement, which came a day before the start of the Republican National Convention, researchers struggled to sort the politics from the medical and scientific import of the EUA.
Arturo Casadevall is quoted.

August 25, 2020
The New York Times

F.D.A. ‘Grossly Misrepresented’ Blood Plasma Data, Scientists Say
Experts discuss a statistic used by administration officials when announcing the FDA's emergency use authorization for convalescent plasma treatment. The number has no clear origin.
Arturo Casadevall is quoted.

August 25, 2020
ABCNews.com

Emergency plasma authorization sparks concern for those leading charge on treatment
In the high-pressure push to combat COVID-19, two things have become abundantly clear: we need effective treatment and we need further data to inform our findings.
Arturo Casadevall is quoted.

August 25, 2020
Bloomberg

FDA Head Walks Back Claim of Dramatic Benefit From Covid Therapy
The head of the U.S. Food and Drug Administration has reversed the claim that an experimental therapy had provided a dramatic benefit to Covid-19 patients. “What I should have said better is that the data show a relative risk reduction not an absolute risk reduction,” said Stephen Hahn.
Arturo Casadevall is quoted.

August 24, 2020
The Washington Post
Trump touts FDA’s emergency authorization of convalescent plasma as historic breakthrough, but scientists are doubtful
Arturo Casadevall discusses the importance of the FDA support for emergency authorization use of convalescent plasma as a treatment against the coronavirus.

August 24, 2020
NPR
NIH Warns Data On Effectiveness Of Convalescent Plasma In Treating COVID-19 Is Weak [Radio]
Arturo Casadevall discusses the importance of convalescent plasma treatment and early promising results in advance of clinical trials.

August 20, 2020
WBAL
Test allows swabbing for coronavirus on surfaces, designed to help determine risks [Video]
A new test is now available that allows people to swab for the coronavirus on surfaces in public places. This technology could help determine whether schools and businesses are doing a good job of disinfecting.
Andy Pekosz is featured.

August 20, 2020
Scientific American
Why Some People Get Terribly Sick from COVID-19
What determines if someone gets desperately ill from the disease that is ripping its way across the planet? You are likely familiar with the broad categories of people who face greater risk: older individuals, men, those who have certain chronic conditions, and in some countries people of color. Researchers are looking deeper into these groups to determine the underlying roots, both biological and social, for their vulnerability.
Sabra Klein, Sherita Golden and Erin Michos are quoted.

August 18, 2020
CNN.com
Researchers hope this old-fashioned treatment will work for coronavirus
President Donald Trump and US health leaders have done a full court press to encourage people who survived Covid-19 to donate plasma to help those who are sick.
Arturo Casadevall is quoted.

August 17, 2020
The Associated Press

‘Are you doing OK?’: On the ground with NYC contact tracers
Comparing U.S. state and city contact tracing programs is difficult because they vary widely in what they release, but some public health scholars say the numbers that New York reports are promising.
Emily Gurley is quoted.

August 17, 2020
Gizmodo

The Biggest Unanswered Questions About a Covid-19 Vaccine
A vaccine for the coronavirus that causes covid-19 appears to be our best strategy to ending the current pandemic. Unfortunately, the fastest time frame in which scientists have managed to create any vaccine in history was four years, and there’s already plenty of skepticism surrounding the safety, availability, and effectiveness of any future covid-19 inoculation.
William Moss is quoted. 

August 14, 2020
Bloomerg 

Covid-19 Transmission Not Strong on Surfaces: Johns Hopkins [Video]
Andy Pekosz discusses the possibility of Covid-19 reinfection, coronavirus transmission, and concerns about valve masks.

August 11, 2020
The Scientist
Noel Rose, Who Demonstrated Autoimmunity Exists, Dies at 92 The Johns Hopkins University researcher bucked the prevailing idea that the body would not launch an immune response against its own tissues, and in doing so established an entirely new scientific discipline.

August 10, 2020
Bloomberg
Difficult to Justify Full Return to School: Johns Hopkins’ Pekosz [Video]
Andrew Pekosz discusses questions surrounding the return of children to school and looks at phase three vaccine trials.

August 10, 2020
Wired
The US Is Disastrously Behind in Covid-19 Testing. Again
With infections rampant in parts of the nation, backlogs are preventing people from getting timely test results, hampering efforts to contain the virus.
Emily Gurley is quoted.

August 10, 2020
Buzzfeed News
Convalescent Plasma Is Looking Like A Coronavirus Success Story

As we await a coronavirus vaccine, the spotlight in COVID-19 treatments is returning to antibodies, the body’s natural defenses against viruses. While almost no US hospitals were using convalescent plasma treatment before April, it is now administered to an estimated 1,500 patients a day in around 2,000 hospitals nationwide.
Arturo Casadevall is quoted.

August 5, 2020
The New York Times

As Trump Praises Plasma, Researchers Struggle to Finish Critical Studies
American scientists are hoping Covid-19 patients in Brazil will help them answer a century-old question: Can this golden serum, loaded with antibodies against a pathogen, actually heal the sick?
Arturo Casadevall is quoted.

August 4, 2020
Associated Press
Baseball teams try to adapt, find safe options on road trips

Gone for now are the days of baseball players, often dirt-stained and still in uniform, gathering in the clubhouse to scarf down a late night meal before heading their separate ways until doing it all again some 24 hours later. Emily Gurley is quoted. 

August 4, 2020
CNN.com
Do some people have protection against the coronavirus?
A recently published summary article in the journal Nature Reviews Immunology put forth a tantalizing possibility: A large percentage of the population appears to have immune cells that are able to recognize parts of the SARS-CoV-2 virus, and that may possibly be giving them a head start in fighting off an infection. In other words, some people may have some unknown degree of protection.
Arturo Casadevall is quoted.

August 3, 2020
The Los Angeles Times

Amid a pandemic response that promises marvels of genetic engineering, vaccines developed at “warp speed” and artificial intelligence at the bedside, it takes courage for a scientist to dust off a remedy from the history books and propose it as modern medicine.
Arturo Casadevall is quoted.

August 3, 2020
Voice of America
Researchers are testing a fungus known to grow in high radiation environments to see if it could possibly protect humans traveling in space. One fungus being studied survived – even thrived – in areas around the former Chernobyl nuclear power center in Ukraine.
Radamés J.B. Cordero is quoted. 

August 3, 2020
Associated Press
Cardinals contact tracer finds ‘tricky balance’ in new role

After 20 years in baseball ranging from media relations to international scouting, Moisés Rodríguez is in a role he never imagined — contact tracer during a coronavirus pandemic.
Emily Gurley is quoted. 

July 31, 2020
NBC News
As California coronavirus cases spike, contact tracing stalled by fear and embarrassment
Factors such as testing delays, distrust and embarrassment are combining to make efforts to contain COVID-19 more difficult in the state that now has the highest number of cases in the nation.
Emily Gurley is quoted.

July 30,2020
Healthline

3 More COVID-19 Vaccines Move Toward Final Stage of Testing
Three more COVID-19 investigational vaccines have been shown in early clinical trials to be generally safe and to induce an immune response in healthy volunteers.The results of two of these studies were published online yesterday in The Lancet. One is a phase 1 and 2 trial by researchers at Oxford UniversityTrusted Source with support from AstraZeneca. The other is a phase 2 trial by Chinese researchers supported by CanSino BiologicsTrusted Source.
Naor Bar-Zeev and William Moss, who coauthored an editorial cited in the article, are quoted. 

July 27, 2020
Bloomberg

Bloomberg Surveillance [Video]
Andy Pekosz discusses the severity of Covid-19 infections and how they appear to be less severe in individuals under the age of ten.
He is featured around the 1:57:40 mark

July 24, 2020
Fox 8
Antibodies disappear quickly in some people who had COVID-19 says study; Tulane & Johns Hopkins experts react [Video]

With no COVID-19 vaccine approved yet, there is a lot of focus on antibodies, proteins that develop after someone has been infected with the virus. Antibodies are supposed to help fight off infection and provide protection against re-infection. But UCLA research published this week in the New England Journal of Medicine found that in some people the antibodies disappeared or decayed quickly. Arturo Casadevall is featured.

July 22, 2020
Physician's Weekly

Covid-19: Early, Promising Results for Three Vaccines
As the Covid-19 pandemic rages on, the race for a vaccine is heating up. On Monday, July 20, promising early results of three vaccine trials were announced, two published in The Lancet — one from the University of Oxford and AstraZeneca, and the other from CanSino Biologics — and the third, from Pfizer and BioNTech, published by medRxiv, the results of which have not yet been peer reviewed.  William Moss and Naor Bar-Zeev, who coauthored an editorial cited in the article, are quoted.

July 22, 2020
The Hill 

How excited should we be about coronavirus vaccine progress and what is dual immune action?
On Monday, the medical journal The Lancet published two studies about two promising vaccine candidates. The Oxford University group based at Jenner Institute tested their vaccine on more than 1,000 people. A biotech group in China called CanSino tested their vaccine on about 500 participants.
William Moss and Naor Bar-Zeev, who coauthored an editorial cited in the article, are quoted. 

July 22, 2020
Scientific American

Contact Tracing, a Key Way to Slow COVID-19, Is Badly Underused by the U.S.
Across the U.S., states that once acted as if the pandemic was going away are setting new daily records for infections, hospitalizations and deaths. There is one proved tool that has helped other countries stem the pandemic -- contact tracing. But in the U.S. it is severely underused.
Emily Gurley is quoted.

July 22, 2020
CNN

Oxford's Covid-19 vaccine appears safe and induces immune response, early results suggest, but more research is needed
Results from trials involving three different coronavirus vaccines released Monday, all showing positive results, with evidence the vaccines can produce immune responses that would be expected to protect people against infection.
William Moss and Naor Bar-Zeev, who coauthored an editorial cited in the article, are quoted.

07/20/20
Bloomberg [Video]
Virus Case Level Is ‘Disconcerting’: Johns Hopkins’ Pekosz
Andrew Pekosz discusses the surge in U.S. coronavirus cases, and how the virus is impacting younger individuals.

July 17, 2020
Bloomberg [Video]

Covid-19, Influenza Mix ‘Inevitable’ in Fall: Johns Hopkins’ Adalja
Andrew Pekosz discusses the surge in U.S. coronavirus cases, and how the virus is impacting younger individuals.

July 14, 2020
Bloomberg [Video]

Plasma Treatment Results Encouraging: Johns Hopkins' Casadevall
Arturo Casadevall discusses his latest work and the impact of convalescent plasma in the fight against Covid-19. 

July 13, 2020
Boston Globe [Paywall]

While the European Union recovers, the United States splinters
Three months after the death tolls reached their devastating peaks, the two unions are charting increasingly divergent paths. Europe is recovering, swiftly and definitively, while the United States stalls and splinters.
Bill Moss is quoted.

July 10, 2020
CBS This Morning

Coronavirus gender gap: Scientists try to explain why men are much more likely to die of COVID-19
Researchers have been studying the effects of the coronavirus on both men and women, and they've found that men are more likely to suffer worse outcomes from the disease, and are as much as 2.4 times more likely to die. Sabra Klein is featured.

July 8, 2020
USA TODAY

Coronavirus is revolutionizing scientific practices and communication. Here's how
Just as everyday life has been affected by COVID-19, science itself has changed. Scientists have had to learn how to produce meaningful information for a world clamoring for speedy results. 
Arturo Casadevall is quoted.

July 1, 2020
Bloomberg

Coronavirus Cases Top 48,000, Virus Keeps Spreading in South [Video]
Andrew Pekosz discusses the surge in U.S. coronavirus cases, and what is being learned about how the virus works within the human body.

June 22, 2020
BBC

Are more women dying of Covid-19 in India?
New research by a group of scientists in India and US shows that although men make up the majority of infections, women face a higher risk of dying from the coronavirus than men.
Sabra Klein and Kunihiro Matsushita are quoted.

June 15, 2020
The Hill

Trust but verify: The US government needs to validate antibody tests
If serology test results are to be used in public health decision making—such as reporting the true prevalence of a disease or changing reported case fatality rates — the tests used must be as dependable as possible.
Gigi Gronvall and Rachel West wrote the article

June 15, 2020
Bloomberg

[VIDEO] Global Coronavirus Cases Top 7.5 Million; 420,000 Deaths Recorded
Reopening economies too early risks a fast rebound of infections
Andrew Pekosz is interviewed.

June 15, 2020
National Geographic

How long does the coronavirus last inside the body?
Researchers are narrowing down how long the virus persists inside the body and whether people can be quickly re-infected.
Diane Griffin is quoted.

June 11, 2020
Bloomberg

Bloomberg Daybreak: June 10, 2020 – Hour 2 [Audio]
Protests over the past week have raised concerns over the possibility of a spike in coronavirus cases, and mixed messaging on how COVID-19 spreads has created nationwide confusion.
Andy Pekosz is introduced at the 14:30 mark

June 11, 2020
NPR – Goats and Soda

Why Forecasters Can’t Make Up Their Mind About Africa And The Coronavirus
When the new coronavirus started spreading around the world, there were dire warnings about what would happen when it hit African countries. Now, there are a range of predictions – from pessimistic to guardedly optimistic.
Shaun Truelove and William Moss are quoted.

June 8, 2020
Bloomberg

Loosening Covid-29 Restrictions Shows Mixed Results [Video]
Andrew Pekosz updates work on vaccines and antibody treatments for Covid-19 and examines the spread of the virus as public restrictions are loosened in the United States.

June 5, 2020
WebMD

Plasma Therapy Helps Critically Ill COVID Patients
The blood plasma of people who have recovered from the new coronavirus infection may help critically ill COVID-19 patients recover, a new study finds.
Arturo Casadevall is quoted.

June 4, 2020
U.S. News & World Report

Plasma Therapy Aids Recovery in Critically Ill COVID-19 Patients
The blood plasma of people who have recovered from the new coronavirus infection may help critically ill COVID-19 patients recover, a new study finds.
Arturo Casadevall is quoted.

June 2, 2020
Los Angeles Times

Engineer? Cancer expert? Physicist? They’re coronavirus researchers now
David Sullivan usually studies malaria in remote regions of Bangladesh and Africa. That work has made him an expert on the drug chloroquine, which showed apparent promise as a COVID-19 treatment in the outbreak’s earlier days. But after his colleagues at Johns Hopkins University pulled him into COVID-19 discussions, he noticed a research gap in a very different part of the pandemic fight: convalescent plasma.

June 2, 2020
Consumer Reports

What Socializing, Going to Work and School Might Look Like as States Reopen Amid the Pandemic
What was long thought of as “normal” is not coming back anytime soon. But after the current phase of lockdown ends, there will be a new normal—less restrictive than simple stay-home orders, but far different from what we knew before.
William Moss and Crystal Watson are quoted.

May 29, 2020
Bloomberg

Antibody Tests Don’t Tell If Protected From Reinfection: Johns Hopkins [Video]
Andrew Pekosz discusses antibody testing and wearing masks as part one of protection against Covid-19.

May 28,2020
USA TODAY

Use of survivor plasma is considered safe, but two new tests will see if it combats COVID-19
Two new clinical trials will begin this week testing plasma from patients who have recovered from COVID-19 on people who have been exposed to the virus, or are in the early stages of the disease.
Arturo Casadevall is quoted.

May 26, 2020
Bloomberg

Latin America, Africa Are Fast Becoming the New Virus Front Lines [Video]
Andrew Pekosz discusses the rising concern over the spread of the coronavirus in Latin America and Africa

May 15, 2020
Bloomberg

Reopening Needs a Different Kind of Covid-19 Monitoring: Johns Hopkins [Video]
Andrew Pekosz discusses taking a different approach to Covid-19 testing and monitoring as economies begin to reopen.

May 13, 2020
U.S. News & World Report

Could Survivors’ Blood Help Patients Battling COVID-19? Trials May Tell
Could blood plasma drawn from people who've recovered from COVID-19 help prevent new coronavirus infections or ease symptoms in those already infected?
Arturo Casadevall is quoted.

May 12, 2020
VOA

US College Student Who Overcame COVID-19 Donates Plasma to Research
Twenty-year-old Leo Canty says he was worried less about himself and more about the people around him when he tested positive for COVID-19. The college student was determined to donate his plasma for potential therapy for both prevention and treatment in the fight against the coronavirus.
Arturo Casadevall is quoted.

May 11, 2020
The Wall Street Journal

Covid-19 Raises Questions About the Value of Personalized Medicine [Paywall]
A group of medical dissenters argues that tailoring treatment to the genetic profiles of individuals, a longstanding goal for researchers, is less important than the old-fashioned public health measures being used against the pandemic.
Arturo Casadevall is featured.

May 11, 2020
Bloomberg

Johns Hopkins Envisions ‘Massive Vaccination Program’ for Covid-19 [Video]
Relentless work is being done on finding a coronavirus vaccine, and now mobile apps will be used to conduct contact tracing.
Andrew Pekosz is interviewed.

May 11, 2020
The Baltimore Sun

Blood of those recovered from COVID-19 could ‘head the disease off at the pass,’ health experts say
A donation program, part of an initiative at LifeBridge Health, is joining numerous hospitals and universities around the country in exploring the use of convalescent blood plasma as a therapy for people suffering from COVID-19.
Arturo Casadevall and David Sullivan are quoted.

May 11, 2020
CBS News

Using plasma transfusions to treat COVID-19
Convalescent plasma may just be a stop-gap measure against COVID-19 until more treatments and a vaccine come along. But doctors have already used donated plasma on thousands of patients, and are finding some success with a procedure that dates back more than 120 years.
Arturo Casadevall is featured.

May 11, 2020
Healio

Johns Hopkins begins trials of blood plasma for COVID-19 treatment, prophylaxis
Two randomized, placebo-controlled clinical trials at Johns Hopkins Medicine aim to determine whether blood plasma will be effective as prophylaxis against COVID-19, a strategy that would be “enormously valuable” and has been efficacious against other viral diseases.
Arturo Casadevall is quoted.

May 7, 2020
WBAL TV 11 - NBC

Maryland pediatricians worry as parents cancel child checkups, vaccinations
Pediatricians around Maryland are growing more and more concerned as more parents are canceling well-child checkups and vaccinations out of fear of becoming infected with coronavirus.
William Moss is quoted.

May 5, 2020
Business Insider

How climate change could make infectious diseases even more difficult to combat in the future
Researchers fear the current pandemic could only be the beginning of a new battle against infectious disease outbreaks—the World Health Organization warns that climate change could make the spread of disease even worse in the coming decades.
Arturo Casadevall is quoted.

May 5, 2020
Bloomberg

Covid-19: Johns Hopkins Sees ‘Great Hope’ in Antibodies Research [Video]
Andy Pekosz discusses testing of existing medicines as coronavirus treatments, and the importance of antibody research and testing.

May 5, 2020
Bloomberg

Hope for Antibody Testing [Podcast]
Andy Pekosz joins the show at the 27:55 mark.

April 30, 2020
Inverse

Why is COVID-19 Killing More Men Than Women? Scientists Have 4 Theories
"Being male is a risk factor for death from Covid-19."
Sabra Klein is quoted.

April 30, 2020
FiveThirtyEight

Why Are More Men Than Women Dying of COVID-19?
While men account for the majority of COVID-19 cases in some countries but a minority of cases in others, they consistently make up the majority of deaths.
Sabra Klein is featured.

April 28, 2020
WebMD

COVID-19 Antibody Testing Brings Cautious Hope
Antibody testing has the potential to help determine when Americans can return to work and resume normal activities, as well as who can donate blood that can be used to make convalescent plasma to help those who are gravely ill.
Diane Griffin is quoted.

April 28, 2020
National Geographic

What you should know about experimental therapies for coronavirus [Paywall]
Here are some of the coronavirus therapies currently being tested, with estimates of how soon they might be widely available for the general public.
Arturo Casadevall is quoted.

April 28, 2020
Maryland Public TV – Direct Connection

COVID-19 Crisis [Video]
When host Jeff Salkin talked to the show’s first coronavirus expert, from the Johns Hopkins Bloomberg School of Public Health, Maryland had 0 reported cases. 8 weeks later, over 800 people have lost their lives statewide, and over 1,500 are currently hospitalized.
Andy Pekosz rejoins the show.

April 27, 2020
The New York Times

Can Estrogen and Other Sex Hormones Help Men Survive Covid-19? [Paywall]
Men are more likely than women to die of the coronavirus, so scientists are treating them with something women have more of: female sex hormones.
Sabra Klein is quoted.

April 27, 2020
CBS News

State Department says coronavirus samples from China "critical" for developing vaccine; Experts say that's not the case
Some medical experts interviewed by CBS News question some of the administration's claims about whether China's lack of transparency is actually blocking the world from developing a vaccine.
Andrew Pekosz is quoted.

April 24, 2020
NPR

Researchers Look To Behavior To Explore Why The Coronavirus May Hit Men Harder
Researchers suspect that the coronavirus is hitting men and women differently. Worldwide, men appear more likely to suffer more severely or die from COVID-19 than women.
Research led by Sabra Klein is mentioned.

April 24, 2020
Bloomberg

[Video] Coronavirus Treatment: Topical vs. Internal Remedies
Explaining distinctions between topical and internal virus treatments, and the timeline for vaccine testing.
Andrew Pekosz is featured.

April 22, 2020
FOX 17 – Nashville

A potential COVID-19 vaccine without a shot? One research team is working on a patch
What if you could one day get coronavirus protection without a shot? One research team in Pittsburgh is working on a small skin patch it says has the potential to stick it to the coronavirus in an innovative way.
William Moss is featured.

April 21, 2020
GQ

Why Does Coronavirus Disproportionately Kill Men?
While many mysteries remain, one attribute of the virus that has become clear is that more men than women are dying of Covid-19, the infectious disease that coronavirus can cause in humans.
Sabra Klein is quoted.

April 20, 2020
TIME

California Doctor Selling False ‘Miracle Cure’ for COVID-19 Charged With Mail Fraud
A California doctor accused of hawking a supposed “miracle cure” for COVID-19 is facing up to 20 years in prison for fraud.
David Sullivan is quoted.

April 17,2020
Bloomberg

Covid-19 Causes Broad Spectrum of Diseases: Johns Hopkins’ Pekosz [Video]
Andy Pekosz explains what is being learned about patterns of coronavirus infections, the uncertainties of testing, and questions about immunity and reinfection.

April 17,2020
WBAL TV 11

Medical experts share when things could return to normal for Maryland
It's been more than a month since the coronavirus pandemic hit Maryland, but medical experts don't expect a peak to hit until sometime next in May.
William Moss is quoted.

April 17,2020
Newsweek

To Treat Coronavirus, An Old Therapy Is Offering New Hope [Opinion]
In the current COVID-19 pandemic, both China and Italy have used convalescent plasma as a treatment, and the emerging data is encouraging.
Arturo Casadevall is mentioned.

April 16,2020
Mother Jones

Inside One Family’s Desperate, Hopeful, Facebook-Fueled Search for Plasma
Kellie Burns, a former health care consultant who’d been tuning into New York Gov. Andrew Cuomo’s daily coronavirus briefings, had determined that an experimental transfusion of convalescent plasma was the least risky, most feasible option to give her father a fighting chance in his battle with the coronavirus.
Arturo Casadevall is quoted.

April 14, 2020
Bloomberg

Tracking the Path of the Coronavirus Outbreak [Audio]
Andy Pekosz discusses tracking the path at the coronavirus outbreak.
He is introduced to the podcast at the 1:50 mark

April 13, 2020
Politico

How to manage your coronavirus stress
Most of us have made huge changes in our lives over the past month and are facing an uncertain future, all while trying to wrap our heads around a global health and economic mess.
Sabra Klein is featured.

April 13, 2020
Yahoo! News

COVID-19: Young Boys At Higher Risk Of Infection and Severe Illness From Coronavirus, Says Study
In a study of over 2,500 children—aged 0 to 18—with COVID-19, some 57 percent were male, suggesting that “biological factors” could make men more susceptible to the virus.
Sabra Klein is quoted.

April 8, 2020
International Business Times

Coronavirus Update: NY COVID-19 Patients Are Being Treated With Anti-Malarial Drug
There is little scientific evidence on the efficacy of an anti-malarial drug combination to fight COVID-19. State officials, however, are banking their hopes on a small study showing that the drug may have helped a small group of patients who were mildly ill from COVID-19 to recover.
David Sullivan is quoted.

April 7, 2020
Bloomberg

It’s Still Hard to Predict Who Will Die From Covid-19 [Opinion]
Although the initial epidemiological data show that Covid-19 is more severe in older people, men and those with pre-existing conditions, not everyone with severe disease has these risk factors. And not everyone at risk has the same symptoms, prognosis or outcome.
Arturo Casadevall co-wrote the piece.

April 6,2020
The Washington Post
All across the United States, the coronavirus is killing more men than women, data show [Paywall]
An emerging body of research has revealed that women’s bodies are better at fighting off infection, thanks to the hormones in their systems and the genes on their two X chromosomes.
Sabra Klein is quoted

April 6, 2020
New York Post

Researchers able to test if blood plasma of coronavirus survivors can protect health care workers
Researchers at Johns Hopkins University now have federal approval to test if blood plasma from recovered COVID-19 patients can help protect the heroes on the front line of the battle against coronavirus.
Arturo Casadevall has amassed a team of physicians and scientists from around the country who are now establishing a network of hospitals and blood banks that can collect, isolate and process blood plasma from COVID-19 survivors.

April 6, 2020
The New York Times

Does Covid-19 Hit Women and Men Differently? U.S. Isn’t Keeping Track [Paywall]
Data from other countries shows that more men are dying from the virus than women — a discrepancy that should inform the response and vaccine research in the U.S. But it isn’t.
Sabra Klein is quoted.

April 6, 2020
The New York Times

C.D.C Recommends Wearing Masks in Public; Trump Says, ‘I’m Choosing Not to Do It’ [Paywall]
President Trump said on Friday that the Centers for Disease Control and Prevention was urging all Americans to wear a mask when they leave their homes, but he immediately undercut the message by repeatedly calling the recommendation voluntary and saying that he would not wear one himself.
Sabra Klein is quoted.

April 3, 2020
The Wall Street Journal

Coronavirus Survivors Keep Up the Fight, Donate Blood Plasma to Others [Paywall]
A national Covid-19 project seeks volunteers to aid the seriously ill.
Arturo Casadevall is featured.

April 2, 2020
USA Today

The first coronavirus patients are being treated with convalescent plasma therapy. Will it work? Not even the doctors know.
Whether the plasma, derived from the blood of people who have recovered from COVID-19, will help them fight off the devastating disease is still unknown. But in less than 3 weeks, the effort to find out has gone from an idea to a worldwide program entirely self-organized by medical researchers.
Arturo Casadevall is quoted

April 1, 2020
France24

Coronavirus: Why do more men die of Covid-19 than women?
As the world faces the most serious public health crisis in a century, scientists and professionals are scrambling to understand who is most vulnerable to Covid-19 and why.
Sabra Klein is quoted.

March 30, 2020
Buzzfeed

Survivors Of COVID-19 May Hold The Key For Everyone Else — In Their Blood
This week, researchers in New York City started collecting blood from COVID-19 survivors. The hope is that their immunity can be shared with others.
Arturo Casadevall is quoted.

.March 30 2020
The Washington Post

Blood from people who recover from coronavirus could provide a treatment
Plasma is being studied as a way to fight off the virus
Arturo Casadevall and Evan Bloch are quoted

March 27, 2020
The Washington Post

Men are getting sicker, dying more often of covid-19, Spain data shows [Paywall]
Pneumonia cases, hospitalizations, ICU visits, death and even basic symptoms were more frequent in males.
Sabra Klein is quoted.

March 26, 2020
NPR

FDA Expedites Treatment Of Seriously Ill COVID-19 Patients With Experimental Plasma
The FDA is facilitating access to COVID-19 convalescent plasma for use in patients with serious or immediately life-threatening COVID-19 infections.
Arturo Casadevall, who co-championed the idea, is featured.

March 26, 2020
Nature

How blood from coronavirus survivors might save lives
Hospitals in New York City are gearing up to use the blood of people who have recovered from COVID-19 as a possible antidote for the disease.
Arturo Casadevall who has been fighting to use blood as a COVID-19 treatment since late January, is featured.

March 26, 2020
The Guardian

Men are much more likely to die from coronavirus—but why?
Behavioural factors that differ across genders may have a role in fatality rates of the coronavirus. However, there is a growing belief among experts that more fundamental biological factors are at play.
Sabra Klein is quoted.

March 24, 2020
NBC News

New York will be first state to test treatment of coronavirus with blood from recovered patients
Hoping to stem the toll of the state’s surging coronavirus outbreak, New York health officials plan to begin collecting plasma from people who have recovered and injecting the antibody-rich fluid into patients still fighting the virus.
Arturo Casadevall is quoted

March 23, 2020
The Washington Post

Major universities suspend most lab research—but not into coronavirus [Paywall]
A growing number of universities are suspending nonessential research, another sign of the vast disruption the pandemic is wreaking, with faculty members and graduate students racing to close labs.
Arturo Casadevall is quoted.

March 23, 2020
Forbes

This Coronavirus Patient Dodged A Bullet With Hydroxychloroquine. Is She A Harbinger or Outlier?
Given the life and death situation of hospitalized patients with COVID-19 and the possibility that hydroxychloroquine plus azithromycin may be helpful, it is valuable and ethical for authors of drug-testing studies to report results.
Ying Zhang is quoted

March 20, 2020
The Washington Post

The coronavirus is killing far more men than women
Upwards of 70 percent of deaths in Italy have been men. The question is: Why?
Sabra Klein is quoted.

March 20, 2020
Fox News

More men dying from coronavirus than women, data suggests
More than 10,000 people have died from the novel coronavirus, with men seemingly hit harder by the virus than women, according to early data.
Sabra Klein is quoted.

March 19, 2020
Milwaukee Journal Sentinel (USA Today Network)

Possible coronavirus treatment could be in clinical trials within weeks, using plasma from recovered patients, if doctors get FDA approval
The Johns Hopkins University doctor coordinating a nationwide effort to launch emergency clinical trials of plasma from patients who've recovered from coronavirus said he expects to forward a plan to the U.S. Food & Drug Administration Wednesday and to start treating the first patients in about four weeks.
Arturo Casadevall, who has been organizing the convalescent sera efforts nationwide, is quoted.

March 18, 2020
The Baltimore Sun

Johns Hopkins experts are learning more about the coronavirus. Here’s what they want you to know.
As much of Maryland and the United States hunker down at home to help stop spread of the coronavirus, scientists are making progress in understanding how the virus is transmitted, how it affects humans and, most importantly, how it can be stopped.
Experts at the Johns Hopkins Bloomberg School of Public Health offered some updates and things people can do now. This Q&A is adapted from a webcast moderated by Dr. Joshua Sharfstein, and includes Andy Pekosz and Caitlin Rivers.

.March 17, 2020
The New York Times

How Long Will the Coronavirus Outbreak and Shutdown Last? [Paywall]
Public health officials say a coronavirus vaccine won’t be ready for widespread public use for at least a year to 18 months, taking us well into 2021.
Andrew Pekosz is mentioned.

March 16, 2020
Forbes

How Bad Will the COVID-19 Coronavirus Epidemic Get In the U.S.? Health Experts Weigh In
How bad might the COVID-19 outbreak get in the United States, and what measures are needed to contain it? We reviewed statements from government health officials and surveyed infectious disease experts to forecast the coming weeks.
Andrew Pekosz is quoted.

March 16, 2020
The Baltimore Sun

Johns Hopkins researcher wants to fight coronavirus with a serum made from the blood of recovered patients
In an article published Friday in the Journal of Clinical Investigation, researcher Arturo Casadevall argues that blood injections from patients who have recovered from COVID-19 might help protect at-risk people — including health care workers and family members caring for sick relatives — from falling prey to the disease

March 5, 2020
Allure

The Difference Between a Surgical Mask and a Respirator Mask
There are two types of masks used in preventing infections: surgical masks and respirator masks. It’s important to know the difference, and which situations they’re useful in.
Andrew Stanley Pekosz is quoted.

March 3, 2020
The Philadelphia Inquirer

How a Pennsylvania doctor stopped a virus outbreak in 1934—with blood
J Roswell Gallagher took a decisive step in 1934 to tackle a measles outbreak that has relevance for how the world responds to the new coronavirus.
Arturo Casadevall is quoted.

March 3, 2020
Maryland Public Television

Direct Connection
Andrew Pekosz is featured for the full show, hosted by Jeff Salkin, discussing the latest coronavirus/COVID-19 news.

March 3, 2020
CBS News

The passengers in his cab were coughing but wearing but wearing face masks. He still caught the coronavirus
A taxi driver in Thailand likely caught the coronavirus from Chinese tourists who were passengers in his cab. The tourists were coughing but wearing face masks, the driver said. He still caught the virus, despite the masks.
Andrew Pekosz is featured.

March 2, 2020
NPR

How A Coronavirus Blood Test Could Solve Some Medical Mysteries
As the coronavirus spreads more widely around the globe, scientists are starting to use a powerful new tool: a blood test that identifies people who have previously been exposed to the virus. This kind of test is still under development in the United States, but it has been rolled out for use in Singapore and China.
Andrew Pekosz is quoted.

February 28, 2020
The Wall Street Journal

[Opinion] How a Boy’s Blood Stopped an Outbreak
A school physician’s approach to measles in 1934 has lessons for the coronavirus.
Arturo Casadevall wrote the article.

February 28, 2020
CBS News

The No. 1 way to prevent coronavirus isn’t wearing a face mask
As fears over the coronavirus spread, thousands of Americans are clamoring to buy face masks in an effort to protect themselves, sending prices soaring and leading manufacturers like 3M to ramp up production. However, experts say stocking up on face masks is actually misguided — and there's a much simpler thing you could be doing right now to protect yourself.
Andrew Stanley Pekosz is quoted.

February 28, 2020
NPR

How A Coronavirus Blood Test Could Solve Some Medical Mysteries
As the coronavirus spreads more widely around the globe, scientists are starting to use a powerful new tool: a blood test that identifies people who have previously been exposed to the virus.
Andrew Stanley Pekosz is quoted.

February 21, 2020
The New York Times

Why the Coronavirus Seems to Hit Men Harder Than Women [Paywall]
The coronavirus that originated in China has spread fear and anxiety around the world. But while the novel virus has largely spared one vulnerable group—children—it appears to pose a particular threat to middle-aged and older adults, particularly men.
Sabra Klein is quoted.

February 10, 2020
FOX News
Chernobyl shocker as fungi that eats radiation found inside nuclear reactor
A type of black fungus that eats radiation was discovered inside the Chernobyl nuclear reactor.
A paper co-authored by Arturo Casadevall is cited.

February 5, 2020
Axios

Coronavirus vaccines in development aren't a short-term cure
There are a dozen research projects underway to try to come up with a vaccine for the Chinese coronavirus
Andrew Pekosz is quoted.

February 3, 2020
VOA News

New Tech Could Make Coronavirus Vaccine in Record Time
According to recent reports, a vaccine against the new Wuhan coronavirus may start testing in as little as three months.
Andrew Pekosz is quoted.

January 31, 2020
CGTN

Andrew Pekosz explains the current state of the coronavirus
Professor Andrew Pekosz highlights the importance of tracking possible mutations by having virus data available earlier and warns of the dangers in mild infectious cases.

January 29, 2020
WBAL TV
Medical researcher calls strain of coronavirus ‘serious threat’
This strain of coronavirus is new, unknown, and appears to be very efficient in its movement. The changing virus needs to be closely monitored in case it becomes even better at infecting humans.
Andrew Pekosz is quoted.

1/17/20
Bloomberg
Coca-Cola’s New Drink Innovations [Audio]
William Moss
, Executive Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health, discusses developing vaccine strategies for measles on the featured podcast.
The segment begins at the 10:27 mark.

01/14/20
Bloomberg
There’s Been a Global Resurgence of Measles [Video]
William Moss
discusses the resurgence of measles outbreaks on “Bloomberg Markets.”

12/10/19
Bloomberg
Early Flu Season Cases Much Higher Than Average: Johns Hopkins [Video]
Andrew Pekosz
, co-director of the Johns Hopkins Center of Excellence in Influenza Research and Surveillance, discusses the tracking of regional influenza outbreaks and the importance of vaccinations to avoid the infection.

11/05/19
WBUR 90.9
‘Immune Amnesia’: Why Measles Is Dangerous For Years After Catching It, Study Shows
Research finds that measles, which kills more than 100,000 children a year around the globe, is an even more dangerous germ than previously thought. It can cause what the scientists call "immune amnesia:" Children who catch the measles can lose resistance they had built up to other illnesses.
William Moss is quoted.

11/05/19
The Scientist
Measles Leaves the Immune System Vulnerable to Other Diseases [Opinion]
Two studies present biological evidence that measles infections in unvaccinated children wipe out immune memories of other pathogens, putting the kids at risk of other deadly diseases. William Moss is quoted.

11/05/19
Newsweek
Parents Who Don’t Vaccinate Children Against Measles Risk ‘Destroying’ Their Immune Systems, Scientists Believe
Parents who don't vaccinate their children against measles risk the virus "destroying" their immune systems and making them vulnerable to other diseases, scientists have warned. William Moss is quoted

11/05/19
Inverse
Scientists have learned that the measles virus gives the immune system amnesia
The measles virus may be even more harmful than previously thought, causing potentially deadly damage to immune memory, according to new research.
William Moss is quoted.

10/03/19
Gizmodo
A 1964 Earthquake Might Have Unleashed a Deadly Fungus on the Pacific Northwest
Two decades ago, a rare but deadly fungal infection began killing animals and people in the U.S. and Canada. To this day, no one has figured out how it arrived there in the first place. Now a pair of scientists have put forth their own theory: Tsunamis, sparked by a massive earthquake in 1964, soaked the forests of the Pacific Northwest with water containing the fungus.
A paper co-authored by Arturo Casadevall is cited

10/02/19
BBC News
Tsunamis linked to spread of deadly fungal disease
A major earthquake in Alaska in 1964 triggered tsunamis that washed ashore a deadly tropical fungus, scientists say.
Arturo Casadevall is quoted.

08/30/19
ABC 7 Chicago
The US eliminated measles in 2000; Current outbreak could change that
There's a "reasonable chance" the United States will lose its measles elimination status in October because of ongoing measles outbreaks in New York, according to Dr. Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases.
William Moss and Paul Spiegel is quoted.

08/30/19
Science Mag
Eradication goal splits malaria community
On 9 September, the Lancet Commission on Malaria Eradication, a group of 26 academics from around the globe, will publish a study recommending that the world set a 2050 target for eradication.
William Moss is quoted.

08/28/19
Science Magazine
Is setting a deadline for eradicating malaria a good idea? Scientists are divided
The debate is about more than just the usefulness of bold goals in global health. The focus on eradication has skewed scientists’ and funders’ priorities, says Brian Greenwood, a malariologist at the London School of Hygiene & Tropical Medicine.
William Moss is quoted.

08/25/19
Newsweek

Computer Simulation Just Predicted A Huge Measles Outbreak in Texas, With 4,000 Percent Increase Predicted In Some Communities
Texas could be hit by large measles outbreaks in which up to 400 people fall ill at a time, according to a forecast by researchers investigating low vaccine rates. Between 2003 and 2018, the number of children exempt from vaccines before attending school spiked from 23,000 to 64,000, according to existing research.
William Moss is quoted.

08/25/19
WebMD

Aging Narrows Gender Gap in Flu Vaccine Response
Aging reduces the stronger immune response that women typically have to vaccination, a new study finds.
Sabra Klein, senior author of the study, is quoted.

08/21/19
The Atlantic
Lyme Disease Is Baffling, Even to Experts
But new insights are at last accumulating.
Ying Zhang is quoted

08/19/19
STAT
Could the world see a resurgence of polio? Experts fear a cautionary tale in measles
As measles case counts have exploded around the globe this year, public health officials doggedly trying to rid the world of another disease scourge have watched the numbers rise with some concern.
William Moss is quoted.

08/16/19
Kenosha News
Commentary: The problem with the ‘superbug’ label
Bacterial drug resistance is a major public health problem that potentially affects all of us. Using accurate language is necessary to keep the public optimally informed about this important threat. Arturo Casadevall is quoted.

08/14/19
The Baltimore Sun
The problem with the ‘superbug’ label | Opinion [Paywall]
Bacterial drug resistance is a major public health problem that potentially affects all of us. Using accurate language is necessary to keep the public optimally informed about this important threat. Arturo Casadevall co-wrote the Op-Ed piece.

08/13/19
Star Tribune
Deadly fungal disease may be linked to climate change
Candida auris has become a global health threat since it was identified a decade ago, especially for patients with compromised immune systems.
Arturo Casadevall, co-author of the study, is quoted

08/13/19
Wired
The Desperate Race to Neutralize a Lethal Superbug Yeast
Candida auris has spread rapidly around the globe, seemingly springing from nowhere and exposing the weaknesses in our defenses against new diseases.
Arturo Casadevall, co-author of a featured paper, is quoted.

07/30/19
Business Insider
A mysterious and deadly fungal infection is spreading across the globe, and no one knows how to stop it
A deadly, drug-resistant fungus called candida auris is spreading on a global scale and causing what the Centers for Disease Control and Prevention calls "urgent threats."
Arturo Casadevall is quoted.

07/29/19
The Baltimore Sun
Dr. Keerti Shah, Johns Hopkins scientist who helped create a cervical cancer vaccine, dies
Dr. Keerti V. Shah, a retired Johns Hopkins scientist who helped established the causality of cervical cancer, died of kidney failure Sunday at his home in Ponce Inlet, Florida.
A quote from a statement by the Johns Hopkins Bloomberg School of Public Health is featured.

07/29/19
Salon
New study warns climate crisis may have been pivotal in rise of drug resistant superbug
Research argues Candida auris may be the first example of a new fungal disease emerging from climate change.
Arturo Casadevall is quoted.

07/25/19
Yahoo

Deadly new fungal superbug is worrying doctors — here's what you need to know
The Centers for Disease Control and Prevention is warning about a deadly new fungal superbug called Candida auris fungus, which was first seen in a patient in 2009 in Japan. Scientists say it can be hard to identify with standard lab tests, and now a new study suggests climate change may be fueling it.
Arturo Casadevall is quoted.

07/24/19
Washington Post
Deadly fungal disease may be linked to climate change, study suggests
Researchers in the United States and the Netherlands have a new theory: They propose that global warming may have played a key role and suggest that this may be the first example of a new fungal disease, Candida auris, emerging from climate change, according to a study published Tuesday in mBio, a journal of the American Society of Microbiology.
Arturo Casadevall is quoted.
NOTE: The study was also covered by: CNNNBC NewsThe Baltimore SunNewsweek and Medical Express.

07/17/19
Infection Control Today
Women’s Stronger Immune Response to Flu Vaccination Diminishes With Age
A study suggests that women tend to have a greater immune response to a flu vaccination compared to men, but their advantage largely disappears as they age and their estrogen levels decline.
Sabra Klein, study senior author, is quoted

07/12/19
The Atlantic
A Groundbreaking Study Is Good News for Cats—And People
Researchers studying the cat-poop parasite, Toxoplasma gondii, made a breakthrough that will spare a lot of felines from research.
Isabelle Coppens is quoted.

06/04/19
The Science Times
Genetically-Modified Fungus May Stop the Spread of Malaria
Over the years, various experiments and researches have been put to motion in the hopes of finding a cure that can put an end to Malaria. This time, scientists have decided to use the spider gene to genetically produce a fungus that will, in turn, produce the venom that can quickly put these mosquitoes down.
Marcelo Jacobs-Lorena is quoted.

May 31, 2019
NPR

Scientists Genetically Modify Fungus To Kill Mosquitoes That Spread Malaria
In the hope of finding a new way to fight malaria, scientists have used a spider gene to genetically engineer a fungus to produce a venom that can quickly kill mosquitoes.
Marcelo Jacobs-Lorena is quoted.

May 30, 2019
The Wall Street Journal
‘Range’ Review: Late Bloomers Bloom Best [Paywall]
Journalist David Epstein says that late specialization demonstrably helped elite athletes in many sports. It can serve the rest of us well, too. In his latest book, “Range: Why Generalists Triumph in a Specialized World,” Mr. Epstein makes a well-supported and smoothly written case on behalf of breadth and late starts.
Arturo Casadevall is quoted.

May 29, 2019
MSN
Lyme Disease Can Be Avoided Naturally. Here’s How
Of the 35 essential oils used in a 2018 study as effective forms of treatment against Lyme disease, garlic, myrrh, thyme, cinnamon, allspice berries, cumin and eucalyptus were proven to kill off B. burgdorferi better than standard Lyme antibiotics.
Ying Zhang, lead author of the study, is quoted.

May 20, 2019
The Associated Press
Vaccine rates rise on long-wary ‘hippie’ island near Seattle
The Vashon Island School District has seen a significant increase in fully immunized children. The number of kindergartners who received the required set of state-mandated vaccines jumped by 31% in the past six years, from 56% to nearly 74% in the 2017-18 school year.
William Moss is quoted.

May 14, 2019
Milwaukee Journal Sentinel
Social media, vaccine exemptions to blame for measles outbreak, researcher contends

To fight the measles outbreak that has spread to 23 states, authorities must reduce vaccine exemptions and fight a tide of social media disinformation, a national expert told more than 200 students and faculty Monday at the Medical College of Wisconsin.
Diane Griffin is quoted.

May 8, 2019
The Scientist
Eye for Manipulation: A Profile of Elisabeth Bik [Opinion]
The microbiologist has turned her attention full-time to unearthing problematic figures in papers- for free.
Arturo Casadevall is quoted.

May 8, 2019
NBC News
For cancer patients, fear of measles has upended daily routines
With measles scares happening everywhere from movie theaters to cruise ships to planes, individuals with compromised immune systems and their families are upending their daily routines to avoid getting the highly contagious disease.
William Moss is quoted.

May 7, 2019
The Baltimore Sun
Immunization complacency threatens to undo progress [Opinion]
State and local public health officials are urging parents to make sure their children's immunizations are up to date before the start of school.
William Moss is a co-author of the op-ed

May 1, 2019
PBS

There’s a measles outbreak. Do you need another shot?
If the U.S. loses its “measles elimination” status, it will join Venezuela as the only other country in North and South America with this distinction. Measles was declared eliminated across the Americas in 2016, but within a year, an outbreak sparked in Venezuela that has persisted up to the current day.
William Moss is interviewed.

May 1, 2019
The Washington Post

Promising treatment emerges for ‘persistent’ Lyme bacteria
About 300,000 people a year are infected with Lyme disease through tick bites, and for up to 20 percent of them the condition persists after a course of antibiotics. But just in time for tick season, researchers are now onto a promising treatment for those sufferers.
Ying Zhang, the study’s senior author, is quoted.

April 26, 2019
Nature

First proven malaria vaccine rolled out in Africa— but doubts linger
The RTS,S vaccine is up to 40% effective at preventing malaria in young children.
Sabra Klein is quoted.

April 26, 2019
Contagion Live
World Malaria Day 2019: New Innovations, Same Targets: Public Health Watch
World Health Organization (WHO) officials have announced plans for a pilot study in Malawi of a new vaccine—called RTS,S—to significantly reduce the disease in children. Experts from around the world gather at the Johns Hopkins Malaria Research Institute (JHMRI) in Baltimore, Maryland, for a scientific symposium entitled “Malaria Elimination in Africa” for the 13th World Malaria Day on April 25th.
William Moss is quoted.

April 26, 2019
Newsweek

UNICEF: The Ground for the Global Measles Outbreaks We Are Witnessing Today Was Laid Years Ago
UNICEF announced that 21.1 million children had missed their first dose of the measles vaccine every year over the last eight years.
William Moss is quoted.

April 24, 2019
NPR
World’s First Malaria Vaccine Launches In Sub-Saharan Africa
Health officials are rolling out the first approved vaccine aimed at stopping a human parasite. It's for malaria — and the hopes are that one day the vaccine could save the lives of tens of thousands of children each year.
William Moss is quoted.

March 26, 2019
STAT

The measles virus was down and out. Now it’s primed for a comeback
Some experts believed the world was ready to rid itself of measles once and for all. These days, with massive outbreaks in the Philippines and Ukraine, more than 80,000 cases in the past year in Europe, and ongoing epidemics in New York, Washington, Texas, Illinois, and California, measles does not feel like an endangered virus.
Williams Moss is quoted.

March 21, 2019
Newsweek
Anti-Vaxxers Are Anti-Vaxxers for One of These Four Reasons
Scientists studying anti-vax posts on Facebook found that the movement doesn't stem from one fear, but rather a range of theories believed by people spanning demographics and the political spectrum.
William Moss is quoted

February 22, 2019
Newsweek
Anti-vax Religious Group Says Sorry For Helping Cause Massive Measles Outbreak
Japan has been undergoing its worst measles outbreak in at least a decade, and one religious order opposed to vaccinations has now apologized for its role in helping to spread the disease.
William Moss is quoted.

February 11, 2019
Palm Beach Daily News
A Woman’s Journey health conference in West Palm Beach draws 300 people
Six health care subjects were covered at “A Woman’s Journey” presented by Johns Hopkins Medicine. The Palm Beach Daily News was one of the sponsors.
Sabra Klein was among the speakers at the 13th annual conference.

February 11, 2019
Newsweek
Children of Anti-Vaxxers Try To Get Vaccinated Without Their Parents Knowing
As Washington state deals with a measles outbreak that has caused at least 53 people—the majority of whom are unvaccinated children—to contract the potentially deadly disease, young people have asked how they can get vaccinated without their parents' knowledge. 
William Moss is quoted.

February 7, 2019
MSN
Measles Outbreak Predicted by Scientists a Year Ago
In a study published almost a year ago, scientists identified "anti-vaxx hotspots"—and the areas flagged include those where cases of measles are being reported. 
William Moss is quoted.

February 1, 2019
Newsweek
2019 Could Be Worst Year For Measles In U.S. For 30 Years: ‘Were Losing Ground To A Disease That Once Killed Millions’
Almost 20 years after measles was eliminated in the U.S., 2019 could see the highest rates of the dangerous disease in three decades, an expert has warned.  
William Moss is quoted.

January 30, 2019
Newsweek
‘In 12 Hours She Was Dead’: Read Roald Dahl’s Heartbreaking Letter to Anti-Vaxxers After His Daughter Died From Measles
A 1986 essay written by the late Charlie and the Chocolate Factory author Roald Dahl about his daughter dying of measles has been shared widely online, as new outbreaks of the dangerous disease have given it fresh relevance.
William Moss is quoted.

December 21, 2018
Science Trends
How Do Living Cells Survive When Skipping A Paycheck?
Recent research on baker’s yeast uncovered a new way cells slow their growth down when nutrients are running low. This information from an improbable source provides new insight into a family of uncharacterized human genes, some of which cause severe neurological disorders, epilepsy, and possible autism when mutated.
J. Marie Hardwick wrote the piece.

December 3, 2018
Science News
Around the world, reported measles cases jumped 31 percent in 2017
Political unrest and refusal to vaccinate is driving the measles surge, health experts say.
Bill Moss is quoted.

November 13, 2018
Reader's Digest
Why the New Flu Drug Is a Game Changer
Everyone should still get their flu shots, but at least we're rolling into this year's flu season with a new weapon: a drug that stops the virus in its tracks.
Andrew Pekosz is quoted

September 28, 2018
Medical Daily
Flu Season Is Starting: 5 Tips To Avoid Falling Sick
Since flu season is right around the corner, it is important to start taking preventative measures. The CDC estimates that influenza has annually resulted in between 9.2 million and 35.6 million illnesses.
Andrew Pekosz is quoted.

September 26, 2018
CNN
Gene editing could eliminate mosquitoes, but is it a good idea?
Researchers have rendered a population of mosquitoes in a lab sterile using the gene-editing tool CRISPR-Cas9 by homing in on a specific target in insect DNA -- the doublesex gene -- raising the possibility of eradicating disease-carrying species of the insect entirely, according to a new study
Conor McMeniman is quoted.

September 8, 2018
Consumer Reports

Is It Too Soon to Get the Flu Vaccine?
Last year’s season set new records both for numbers of children who died from flu and for flu-related hospitalizations. But should people get the shot now, before the flu even arrives in January and February?
Andrew Pekosz is quoted.

August 28. 2018
KJZZ 91.5 – Phoenix
Measles Cases Reach Record High In European Region, WHO Reports

The World Health Organization this week reported cases of measles have hit a record high in the European region.
Bill Moss joins the radio show and weighs in on the concerning increase in measles cases in some parts of the world.

August 21, 2018
The Baltimore Sun

There is no wall against infectious diseases
Biological threats continue to evolve, even as public focus careens from one crisis to another. The Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) of 2013 funded the agencies that maintain a focus on biosecurity, and that act is now up for reauthorization.
Rachel Evans, a PhD student in the W. Harry Feinstone Department of Molecular Microbiology, wrote the piece.

August 20, 2018
NPR
Video: The 7 Dwarfs Whistle While They Work To Fight Malaria
A Disney video details many of the important measures Americans took to protect themselves from malaria, getting rid of standing water, screening windows, papering over cracks in the walls, and even weeding ponds to make it easier for fish to eat mosquito larvae.
William Moss is quoted.

August 10, 2018
STAT News

Graduate biomedical education needs an overhaul. Here’s our version
The training of new scientists has become a highly specialized endeavor that frequently emphasizes the acquisition of factual knowledge instead of skills that are essential for good scientific practice, such as critical thinking, rigorous research design, analysis, and philosophy of science.
Gundula Bosch and Arturo Casadevall wrote the article.

July 30, 2018
Everyday Health
FDA Approves New Drug to Treat Recurrent Malaria
Malaria caused by recurrent Plasmodium vivax (P. vivax) is a difficult-to-treat and life-threatening condition that affects 8.5 million people a year. On July 20th, the FDA approved a new drug to help treat this problem.
David Sullivan is quoted

July 18, 2018
Newsweek
Men Might Recover Faster From Flue Than Women Thanks to a Special Molecule, Study Suggests
Due to a higher presence of a lung-healing protein, men may recover quicker from cases of the flu than women according to a recent study.
Sabra Klein is quoted.

July 13, 2018
The Scientist
Software-Based Chemical Screen Could Minimize Animal Testing
Worldwide, millions of animals are used for toxicity testing of compounds intended for human and environmental use. Now, toxicologists have developed software that can accurately predict the outcomes of assays.
Thomas Hartung is quoted.

July 12, 2018
One India
Zika virus infection may multiply risk of miscarriage, stillbirth
Zika virus could pose a far greater threat to pregnancy than recent studies of miscarriage and stillbirth in human infections have reported. This virus do not show any symptoms and thusraises concerns about the complications which are likely to arise from this condition.
Sabra Klein is quoted.

June 6, 2018
CNN
Measles vaccine recommended for those attending World Cup
Russia has also been heavily affected by the recent outbreak of measles, with more than 800 cases reported in 2018. Children and adults who are traveling to Russia for the World Cup -- which takes place between June 14 and July 15 -- should therefore make sure that they have received two doses of the measles vaccine.
Diane Griffin is quoted.

April 8, 2018
CBC (Canada)
The Kingdom: How Fungi Made Our World
Neither plants nor animals, fungi are the most underappreciated kingdom of the natural world. During a billion years of evolution, they’ve become masters of survival. And yet, fungi have also been integral to the development of life on Earth. In fact, neither land plants nor terrestrial animals would exist without them. Arturo Casadevall is quoted.

March 22, 2018
The San Diego Union Tribune
Common malaria resistance trait discovered in Scripps Research-led study
One-third of Africans carry a previously unknown mutation that appears to help them resist malaria, according to an international study led by scientists from The Scripps Research Institute. If confirmed with more research, the discovery may lead to new malaria drugs, and have implications for the health of those who carry the genetic trait. Sean Prigge is quoted.

 March 14, 2018
The Genetic Literacy Project
CRISPR-edited mosquitoes could dramatically reduce more than 200 million annual cases of malaria
Swatting at mosquitoes is a great start, but if we really want to cut down on the hundreds of millions of malaria cases they cause every year, we're going to need some more effective weapons. Now, researchers from Johns Hopkins have used the CRISPR/Cas9 gene editing tool to engineer mosquitoes that are highly resistant to the malaria parasite, by deleting one specific gene. George Dimopoulos, study lead, is quoted.

March 13, 2018
Fox News
Johns Hopkins scientists genetically engineer malaria-resistant mosquitoes
Bloomberg School researchers engineered mosquitoes which are resistant to the malaria parasite, by deleting a gene called FREP1 which helps malaria survive in the mosquito’s gut. George Dimopoulos, study lead, is quoted.

March 8, 2018
ZME Science
CRISPR edit makes mosquitoes far less likely to pass malaria
Scientists used the CRISPR/Cas9 gene editing technique to deactivate a gene in order to make mosquitoes less likely to get infected by parasites that cause malaria in humans. George Dimopoulos, study lead, is mentioned.

February 22, 2018
Hopkins Bloomberg Public Health Magazine
Outsmarting an Outbreak
Faculty Mention: Douglas Norris
Scientists may soon be able to predict potential outcomes of mosquito-borne illnesses, and quash new ones before they have a chance to spread.

February 17, 2018
NPR
Did Pox virus research put potential profits ahead of public safety?
In the brave new world of synthetic biology, scientists can now brew up viruses from scratch using the tools of DNA technology. The latest such feat, published last month, involves horsepox, a cousin of the feared virus that causes smallpox in people. Critics charge that making horsepox in the lab has endangered the public by basically revealing the recipe for how any lab could manufacture smallpox to use as a bioweapon.
Arturo Casadevall and Tom Inglesby are quoted. (Note: This story ran on NPR outlets across the country.)

February 14, 2018
Nature
Train PhD students to be thinkers not just specialists
Many doctoral curricula aim to produce narrowly focused researchers rather than critical thinkers. That can and must change, writes Gundula Bosch, director of the School’s R3 Graduate Science Initiative, where students learn to apply rigor to their design and conduct of experiments; view their work through the lens of social responsibility; and to think critically, communicate better, and thus improve reproducibility. Arturo Casadevall, who founded the R3 program, is mentioned. 

February 9, 2018
NPR
Blue dye kills malaria parasites – but there is one catch
It's hard to imagine that a blue dye sold in pet food stores in the U.S. to fight fungal infections in tropical fish could be a potent weapon against malaria. A study published this week in The Lancet Infectious Diseases showed that might be possible. Bill Moss is quoted.

January 31, 2018
New York Magazine
Everything You Can Do to Prevent the Spread of Flu
Start with getting the flu shot. However, getting it doesn’t mean you’re immune to the flu. The piece includes advice from experts about actions you can take (and things you can buy) to fight the flu this season and stay healthy throughout the year.
Andy Pekosz is quoted.

January 25, 2018
The Star

Handkerchief nightmare? Beat the common cold by blowing your nose
During the first three days of a common cold, the sufferer is contagious - he or she can pass the cold on to others - so it is recommended that the person stay at home and gets as much rest as possible. Sabra Klein’s research is mentioned.

January 24, 2018
Runner's World
Here’s why you can’t (and shouldn’t) run away from the flu in 2018
Even for strong and healthy runners, this year’s flu is no joke. According to the Centers for Disease Control (CDC), anywhere between 5 and 20 percent of the U.S. population contracts the flu each year. And according to the CDC’s latest report, the virus is particularly dangerous this season. Andrew Pekosz is quoted.

January 23, 2018
Reuters
Mosquito-packed drones could give extra bite to Zika fight
Spraying thousands of chilled, sterile mosquitoes from specially adapted drones could prove a cost-effective way to slash numbers of the insects and curb the spread of Zika and other mosquito-borne diseases, say the backers of the technology. WeRobotics, a non-profit trialing the method, plans to start mosquito-release tests shortly in Latin America. Conor McMeniman is quoted.

Romper
Can You Get Sick from the Flu Shot? Here's What the CDC Has To Say

The CDC says that getting a flu shot does not cause the flu illness, since the vaccine is made either with an inactivated virus that's not infectious, or no virus at all. An inactivated virus means that the virus has been killed. The flu shot may cause a reaction, but it does not cause the flu. Andrew Pekosz is quoted.

January 19, 2018
Forbes
Gates Foundation funds research for new synthetic malaria vaccine
The Wistar Institute will collaborate with the Johns Hopkins Malaria Research Institute and Inovio Pharmaceuticals, Inc. (NASDAQ: INO) on the research initiative, which was created in the lab of David B. Weiner, Ph.D., executive director, Vaccine & Immunotherapy Center, The Wistar Institute. Weiner is a molecular immunologist and considered a DNA vaccine pioneer. The Malaria Research Institute is mentioned.

January 4, 2018
Motherboard
Co-Authored Biomedical Papers List Men as First Authors More Frequently Than Women

Even papers that indicated authors had “contributed equally,” male-female listing was statistically more frequent than female-male listing, the study finds. Arturo Casadevall, study co-author, is quoted.

January 3, 2018
JHU Hub
Biomedical science education needs a new philosophy
Newswise
Perspective: Let’s Put the ‘Ph’ Back in Science PhD Programs

Pilot program at the Johns Hopkins Bloomberg School of Public Health aims to close gaps in graduate science education. Gundula Bosch and Arturo Casadevall, study co-authors, are quoted.

Archive: